These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 12646969)
1. [NSAIDs caused gastric mucosal injury: with a special reference to COX-2]. Sakamoto C J Nippon Med Sch; 2003 Feb; 70(1):5-11. PubMed ID: 12646969 [TBL] [Abstract][Full Text] [Related]
2. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects]. Blain H; Jouzeau JY; Netter P; Jeandel C Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595 [TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of NSAID-induced gastric mucosal damage--search for primary events and role of COX inhibition]. Takeuchi K; Tanaka A; Miyazawa T Nihon Shokakibyo Gakkai Zasshi; 2002 Jul; 99(7):751-9. PubMed ID: 12170703 [No Abstract] [Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors. Perini R; Fiorucci S; Wallace JL Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499 [TBL] [Abstract][Full Text] [Related]
7. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Bhang CS; Lee HS; Kim SS; Song HJ; Sung YJ; Kim JI; Chung IS; Sun HS; Park DH; Lee YS Helicobacter; 2002 Feb; 7(1):14-21. PubMed ID: 11886470 [TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase isoforms in gastric mucosal defence. Peskar BM J Physiol Paris; 2001; 95(1-6):3-9. PubMed ID: 11595412 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury. Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Wallace JL Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035 [TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Bertolini A; Ottani A; Sandrini M Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982 [TBL] [Abstract][Full Text] [Related]
12. Selective COX-2 inhibitors: are they safe for the stomach? Yeomans ND; Cook GA; Giraud AS Gastroenterology; 1998 Jul; 115(1):227-9. PubMed ID: 9649482 [No Abstract] [Full Text] [Related]
16. Role of cyclooxygenase-2 in gastric mucosal defense. Peskar BM; Maricic N; Gretzera B; Schuligoi R; Schmassmann A Life Sci; 2001 Nov; 69(25-26):2993-3003. PubMed ID: 11758826 [TBL] [Abstract][Full Text] [Related]
17. [Coxibs: cyclooxygenase-2 inhibitors]. Turnheim K Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832 [TBL] [Abstract][Full Text] [Related]
18. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Cryer B; Feldman M Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023 [TBL] [Abstract][Full Text] [Related]
20. COX-2-Selective NSAIDs: new and improved? Lichtenstein DR; Wolfe MM JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759 [No Abstract] [Full Text] [Related] [Next] [New Search]